{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:33:13Z","timestamp":1778704393791,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2022027"],"award-info":[{"award-number":["2022027"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2023-0139"],"award-info":[{"award-number":["FO2023-0139"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.dmd.2025.100100","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:08:02Z","timestamp":1747768082000},"page":"100100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of the transcription factor nuclear factor 1 B T&gt;C polymorphism on clozapine metabolism in vivo and expression of intestinal transporters in vitro"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1186-9058","authenticated-orcid":false,"given":"Maria","family":"Solbakk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L\u00f8vsletten","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7261-275X","authenticated-orcid":false,"given":"Birgit M.","family":"Wollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line Skute","family":"Br\u00e5ten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Ingelman-Sundberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6190-2751","authenticated-orcid":false,"given":"Espen","family":"Molden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9896","key":"10.1016\/j.dmd.2025.100100_bib1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.dmd.2025.100100_bib2","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jamapsychiatry.2019.1702","article-title":"Association with hospitalization and all-cause discontinuation among patients with schizophrenia on clozapine vs other oral second-generation antipsychotics: a systematic review and meta-analysis of cohort studies","volume":"76","author":"Masuda","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"10202","key":"10.1016\/j.dmd.2025.100100_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.dmd.2025.100100_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2018.08.016","article-title":"Treatment resistant schizophrenia: clinical, biological, and therapeutic perspectives","volume":"131","author":"Nucifora","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.dmd.2025.100100_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.12r08064","article-title":"Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?","volume":"74","author":"Nielsen","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.dmd.2025.100100_bib6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/brainsci10110840","article-title":"Clozapine: an updated overview of pharmacogenetic biomarkers, risks, and safety-particularities in the context of COVID-19","volume":"10","author":"Dragoi","year":"2020","journal-title":"Brain Sci"},{"issue":"Suppl 8","key":"10.1016\/j.dmd.2025.100100_bib7","first-page":"14","article-title":"Review and management of clozapine side effects","volume":"61","author":"Miller","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.dmd.2025.100100_bib8","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/17425255.2021.1974400","article-title":"Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies","volume":"17","author":"Molden","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100100_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.jcp.0000106221.36344.4d","article-title":"Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients","volume":"24","author":"Rostami-Hodjegan","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100100_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1751-7893.2012.00374.x","article-title":"Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010","volume":"7","author":"Couchman","year":"2013","journal-title":"Early Interv Psychiatry"},{"issue":"6","key":"10.1016\/j.dmd.2025.100100_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/acps.13228","article-title":"Impact of smoking behavior on clozapine blood levels - a systematic review and meta-analysis","volume":"142","author":"Wagner","year":"2020","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"10.1016\/j.dmd.2025.100100_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/FPC.0000000000000347","article-title":"PharmGKB summary: clozapine pathway, pharmacokinetics","volume":"28","author":"Thorn","year":"2018","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"10.1016\/j.dmd.2025.100100_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1124\/dmd.112.050484","article-title":"Characterization of human cytochrome P450s involved in the bioactivation of clozapine","volume":"41","author":"Dragovic","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmd.2025.100100_bib14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1021\/tx100131f","article-title":"Role of human glutathione S-transferases in the inactivation of reactive metabolites of clozapine","volume":"23","author":"Dragovic","year":"2010","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100100_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/FPC.0b013e328354026b","article-title":"Glucuronidation of the second-generation antipsychotic clozapine and its active metabolite N-desmethylclozapine. Potential importance of the UGT1A1 A(TA)(7)TAA and UGT1A4 L48V polymorphisms","volume":"22","author":"Erickson-Ridout","year":"2012","journal-title":"Pharmacogenet Genomics"},{"issue":"7","key":"10.1016\/j.dmd.2025.100100_bib16","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1021\/tx500184c","article-title":"Clozapine promotes the proliferation of granulocyte progenitors in the bone marrow leading to increased granulopoiesis and neutrophilia in rats","volume":"27","author":"Lobach","year":"2014","journal-title":"Chem Res Toxicol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100100_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.2019.18050589","article-title":"Pharmacogenomic variants and drug interactions identified through the genetic analysis of clozapine metabolism","volume":"176","author":"Pardinas","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.dmd.2025.100100_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/0004563216686377","article-title":"Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms","volume":"54","author":"Akamine","year":"2017","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"10.1016\/j.dmd.2025.100100_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41398-020-00888-1","article-title":"Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits","volume":"10","author":"Smith","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.dmd.2025.100100_bib20","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1038\/s41467-023-40846-1","article-title":"NFIB facilitates replication licensing by acting as a genome organizer","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.dmd.2025.100100_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ebiom.2017.05.027","article-title":"Nuclear factor I\/B: a master regulator of cell differentiation with paradoxical roles in cancer","volume":"22","author":"Becker-Santos","year":"2017","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.dmd.2025.100100_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/cpt.2571","article-title":"The polymorphic nuclear factor NFIB regulates hepatic CYP2D6 expression and influences risperidone metabolism in psychiatric patients","volume":"111","author":"Lenk","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmd.2025.100100_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/cts.13422","article-title":"Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits","volume":"16","author":"Lenk","year":"2023","journal-title":"Clin Transl Sci"},{"issue":"5","key":"10.1016\/j.dmd.2025.100100_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/JCP.0000000000001585","article-title":"Metabolite profiling of clozapine in patients switching versus maintaining treatment: a retrospective pilot study","volume":"42","author":"Kylles\u00f8","year":"2022","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.dmd.2025.100100_bib25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40263-017-0469-1","article-title":"Correlation between serum concentrations of N-desmethylclozapine and granulocyte levels in patients with schizophrenia: a retrospective observational study","volume":"31","author":"Smith","year":"2017","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.dmd.2025.100100_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/FTD.0000000000001177","article-title":"Novel identification of cysteinyl derivatives of toxic clozapine nitrenium ions and the effect of valproic acid on metabolite formation: a study using reprocessed high-resolution mass spectra of analyzed therapeutic drug monitoring samples","volume":"46","author":"Wollmann","year":"2024","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.dmd.2025.100100_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JCP.0000000000001507","article-title":"Effect of valproic acid on the metabolic spectrum of clozapine in patients with schizophrenia","volume":"42","author":"Smith","year":"2022","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100100_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1211\/0022357043969","article-title":"Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates","volume":"56","author":"El Ela","year":"2004","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100100_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/JCP.0b013e3181acc372","article-title":"ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine","volume":"29","author":"Jaquenoud Sirot","year":"2009","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100100_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1742-7843.2008.00298.x","article-title":"Antipsychotic drugs inhibit the function of breast cancer resistance protein","volume":"103","author":"Wang","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100100_bib31","first-page":"846","article-title":"Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis","volume":"40","author":"Fischer","year":"1991","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100100_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.toxlet.2013.07.023","article-title":"Reconstitution of the interplay between cytochrome P450 and human glutathione S-transferases in clozapine metabolism in yeast","volume":"222","author":"Vredenburg","year":"2013","journal-title":"Toxicol Lett"},{"issue":"1","key":"10.1016\/j.dmd.2025.100100_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1465-9921-12-133","article-title":"Lung glutathione adaptive responses to cigarette smoke exposure","volume":"12","author":"Gould","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.dmd.2025.100100_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.freeradbiomed.2015.12.018","article-title":"Effect of smoking reduction and cessation on the plasma levels of the oxidative stress biomarker glutathione--Post-hoc analysis of data from a smoking cessation trial","volume":"91","author":"Mons","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"10.1016\/j.dmd.2025.100100_bib35","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/pgs.11.55","article-title":"Relationship between P-glycoprotein and second-generation antipsychotics","volume":"12","author":"Moons","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"10","key":"10.1016\/j.dmd.2025.100100_bib36","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/carcin\/bgi139","article-title":"Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists","volume":"26","author":"Ebert","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.dmd.2025.100100_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tox.2016.07.011","article-title":"Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate","volume":"363\u2013364","author":"Sayyed","year":"2016","journal-title":"Toxicology"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T10:08:56Z","timestamp":1753697336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0090955625091093"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100100","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the transcription factor nuclear factor 1 B T>C polymorphism on clozapine metabolism in vivo and expression of intestinal transporters in vitro","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100100"}}